Private Advisor Group LLC increased its position in Elanco Animal Health Incorporated (NYSE:ELAN – Free Report) by 6.3% in the 4th quarter, according to its most recent 13F filing with the SEC. The ...

Highlights,Elanco Animal Health reported a miss in earnings, with EPS falling short of expectations.,Analysts adjusted their ...

In a big win for House Speaker Mike Johnson, House Republicans got their budget plan through the chamber on a 217-215 vote.

The Prince Edward Island Bioscience Cluster continues to make its mark as a top driver of the province’s growing economy.

Elanco Animal Health Incorporated has entered into an agreement with South Dakota-based Medgene to leverage the company's ...

Elanco Animal Health Incorporated (NYSE: ELAN) today announced it has entered into an agreement with South Dakota-based ...

Ladies and gentlemen, thank you for standing by. Welcome to Elanco Animal Health’s Fourth Quarter 2024 Earnings Conference ...

Full Year 2024 Results Key Financial Results Revenue: US$4.44b (flat on FY ...

Elanco Animal Health inks agreement with Medgene to commercialize highly pathogenic avian influenza vaccine in dairy cattle: Greenfield, Indiana Wednesday, February 26, 2025, 15:0 ...

Elanco Animal Health Incorporated (NYSE:ELAN – Get Free Report) shares reached a new 52-week low during mid-day trading on Tuesday after the company announced weaker than expected quarterly earnings.

A novel parasite protection therapy from Elanco Animal Health received FDA approval in October 2024, and was recently made available on the market with a launch at the 2025 Veterinary Meeting & Expo ...

Elanco Animal Health announced the establishment of an agreement with Medgene, a South Dakota-based biotechnology company, to utilize its advanced vaccine platform technology (baculovirus derived ...